Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress

(MedPage Today) — Low LDL cholesterol was associated with an increased risk of bleeding in patients receiving anticoagulation for venous thromboembolism (VTE). (JAMA Network Open)
Among oral anticoagulants used for secondary VTE prevention, apixaban…

Source link : https://www.medpagetoday.com/cardiology/prevention/115567

Author :

Publish date : 2025-05-13 18:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Low LDL and Bleeding Risk; Improved HoFH Life Expectancy; ANGPTL4 mAb Progress

CVS Drops Obesity Drug; Once-Weekly Growth Hormone; WeightWatchers’ Bankruptcy

HIV Drugs and Alzheimer’s; Duchenne Drug Shows Benefit; PFAS and Cognitive Changes

Related Posts

Some Hormone Therapies Linked to Young-Onset Breast Cancer

A crucial methane-tracking satellite has died in orbit

ACIP Members Show Inexperience, Lack of Understanding at First Meeting, Experts Say

Senate Passes Trump’s Tax Bill With $1 Trillion in Health Cuts

HHS Confirms Contracts With Springer Nature Have Been Terminated

DREAMM-20 Hints at a More Tolerable Path for BCMA-Targeted Therapy in Myeloma

Some Hormone Therapies Linked to Young-Onset Breast Cancer

A crucial methane-tracking satellite has died in orbit

ACIP Members Show Inexperience, Lack of Understanding at First Meeting, Experts Say

Senate Passes Trump’s Tax Bill With $1 Trillion in Health Cuts

HHS Confirms Contracts With Springer Nature Have Been Terminated

DREAMM-20 Hints at a More Tolerable Path for BCMA-Targeted Therapy in Myeloma

Sleep and Alzheimer’s; NIH Cuts to Brain Research; Novel CTE Report

Physical Activity and Rehabilitation in Duchenne Muscular Dystrophy

Categories

Archives